224 related articles for article (PubMed ID: 34370682)
1. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity.
Cartwright DM; Oakey LA; Fletcher RS; Doig CL; Heising S; Larner DP; Nasteska D; Berry CE; Heaselgrave SR; Ludwig C; Hodson DJ; Lavery GG; Garten A
J Endocrinol; 2021 Sep; 251(1):111-123. PubMed ID: 34370682
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide Riboside Supplementation to Suckling Male Mice Improves Lipid and Energy Metabolism in Skeletal Muscle and Liver in Adulthood.
Serrano A; Palou A; Bonet ML; Ribot J
Nutrients; 2022 May; 14(11):. PubMed ID: 35684059
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
[TBL] [Abstract][Full Text] [Related]
6. High Dose of Dietary Nicotinamide Riboside Induces Glucose Intolerance and White Adipose Tissue Dysfunction in Mice Fed a Mildly Obesogenic Diet.
Shi W; Hegeman MA; Doncheva A; Bekkenkamp-Grovenstein M; de Boer VCJ; Keijer J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31614949
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in Mice.
Lozada-Fernández VV; deLeon O; Kellogg SL; Saravia FL; Hadiono MA; Atkinson SN; Grobe JL; Kirby JR
mSystems; 2022 Feb; 7(1):e0023021. PubMed ID: 35076278
[TBL] [Abstract][Full Text] [Related]
8. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
Cantó C; Houtkooper RH; Pirinen E; Youn DY; Oosterveer MH; Cen Y; Fernandez-Marcos PJ; Yamamoto H; Andreux PA; Cettour-Rose P; Gademann K; Rinsch C; Schoonjans K; Sauve AA; Auwerx J
Cell Metab; 2012 Jun; 15(6):838-47. PubMed ID: 22682224
[TBL] [Abstract][Full Text] [Related]
9. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans.
Nascimento EBM; Moonen MPB; Remie CME; Gariani K; Jörgensen JA; Schaart G; Hoeks J; Auwerx J; van Marken Lichtenbelt WD; Schrauwen P
J Clin Endocrinol Metab; 2021 Apr; 106(5):1437-1447. PubMed ID: 33524145
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with nicotinamide induces glucose intolerance and skeletal muscle lipotoxicity in normal chow-fed mice: compared to diet-induced obesity.
Qi Z; Xia J; Xue X; He Q; Ji L; Ding S
J Nutr Biochem; 2016 Oct; 36():31-41. PubMed ID: 27567590
[TBL] [Abstract][Full Text] [Related]
12. Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
Sambeat A; Ratajczak J; Joffraud M; Sanchez-Garcia JL; Giner MP; Valsesia A; Giroud-Gerbetant J; Valera-Alberni M; Cercillieux A; Boutant M; Kulkarni SS; Moco S; Canto C
Nat Commun; 2019 Sep; 10(1):4291. PubMed ID: 31541116
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.
Dollerup OL; Christensen B; Svart M; Schmidt MS; Sulek K; Ringgaard S; Stødkilde-Jørgensen H; Møller N; Brenner C; Treebak JT; Jessen N
Am J Clin Nutr; 2018 Aug; 108(2):343-353. PubMed ID: 29992272
[TBL] [Abstract][Full Text] [Related]
14. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model.
Trajcevski KE; O'Neill HM; Wang DC; Thomas MM; Al-Sajee D; Steinberg GR; Ceddia RB; Hawke TJ
PLoS One; 2013; 8(8):e71747. PubMed ID: 23951235
[TBL] [Abstract][Full Text] [Related]
15. NAD
Crisol BM; Veiga CB; Braga RR; Lenhare L; Baptista IL; Gaspar RC; Muñoz VR; Cordeiro AV; da Silva ASR; Cintra DE; Moura LP; Pauli JR; Ropelle ER
Eur J Nutr; 2020 Sep; 59(6):2427-2437. PubMed ID: 31494696
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A
J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681
[TBL] [Abstract][Full Text] [Related]
17. Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding.
Montgomery MK; Hallahan NL; Brown SH; Liu M; Mitchell TW; Cooney GJ; Turner N
Diabetologia; 2013 May; 56(5):1129-39. PubMed ID: 23423668
[TBL] [Abstract][Full Text] [Related]
18. Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside.
Li Q; Jiang X; Zhou Y; Gu Y; Ding Y; Luo J; Pang N; Sun Y; Pei L; Pan J; Gao M; Ma S; Xiao Y; Hu D; Wu F; Yang L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373163
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Dietary Supplementation with Yerba Mate Ameliorates Diet-Induced Obesity and Metabolic Disorders in Mice by Regulating Energy Expenditure and Lipid Metabolism.
Choi MS; Park HJ; Kim SR; Kim DY; Jung UJ
J Med Food; 2017 Dec; 20(12):1168-1175. PubMed ID: 28872427
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3.
Khan NA; Auranen M; Paetau I; Pirinen E; Euro L; Forsström S; Pasila L; Velagapudi V; Carroll CJ; Auwerx J; Suomalainen A
EMBO Mol Med; 2014 Jun; 6(6):721-31. PubMed ID: 24711540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
